**Core tip:** The use of multi-modality imaging can help radiologist diagnose uncommon tumors in unusual sites. The combination of computed tomography, magnetic resonance imaging, and MR spectroscopy was useful in confirming the diagnosis of malignant epidermoid arising from the third ventricle, an unusual site in routine practice.

INTRODUCTION
============

Epidermoid cysts are an uncommon finding in routine clinical settings. They are slow-growing, benign tumors that grow in the extra-axial areas. Epidermoid cysts account for less than 1% of all intracranial tumors\[[@B1]\]. Intracranial dermoid cysts are often observed in the cranial midline, sub-frontal areas, posterior fossa, and suprasellar cistern\[[@B2]\]. Intraventricular dermoid cysts are extremely rare and have been reported in the fourth ventricle\[[@B2]\]. Current imaging modalities have made it possible to recognize intracranial tumors\[[@B3]\]. The use of radiologic diagnosis for third ventricle epidermoid cysts is almost always possible.

We present a case of epidermoid cysts in the third ventricle in an adult male.

CASE PRESENTATION
=================

Chief complaints
----------------

A 48-year-old male presented to our outpatient department with vomiting, headache, and involuntary micturition.

History of present illness
--------------------------

The above-mentioned symptoms had been present for five days.

History of past illness
-----------------------

The patient had no history of major illness.

Personal and family history
---------------------------

The patient had no relevant family history.

Physical examination upon admission
-----------------------------------

The patient had no pallor. General condition of the patient was normal.

Laboratory examinations
-----------------------

The patient's routine laboratory investigations were within normal limits.

Imaging examinations
--------------------

A non-contrast computed tomography scan of the head revealed a mass arising from the third ventricle appearing hypodense and showing coarse nodular as well as curvilinear calcifications (Figure [1](#F1){ref-type="fig"}).

![A non-contrast computed tomography scan of the head showing a mass arising from the third ventricle appearing hypodense and showing coarse nodular as well as curvilinear calcifications.](WJR-11-74-g001){#F1}

A contrast-enhanced computed tomography (CT) of the head demonstrated minimal perilesional enhancement. The lesion obstructed the hydrocephalus of the lateral ventricles (Figure [2](#F2){ref-type="fig"}). No dilatation of the fourth ventricle was observed. The lesion measured 8-10 Hounsfield units. The maximum size of the lesion measured 77x57 mm on CT scan.

![A contrast-enhanced computed tomography of the head demonstrates minimal perilesional enhancement. The lesion obstructs the hydrocephalus of lateral ventricles (Figure [2](#F2){ref-type="fig"}). The maximum size of lesion measures 77 mm × 57 mm on computed tomography scan.](WJR-11-74-g002){#F2}

Magnetic resonance imaging (MRI) of the lesion revealed a large, lobulated, septated T2 hyperintense mass arising from the third ventricle (Figure [3B](#F3){ref-type="fig"}). It was hypointense on T1-weighted imaging with few cystic areas (Figure [3A](#F3){ref-type="fig"}). Few calcifications were observed within the cystic areas. On diffusion-weighted magnetic resonance imaging, the lesion showed increased restricted diffusion (Figure [3D](#F3){ref-type="fig"}). The lesion obstructed the hydrocephalus and caused moderate dilatation of the bilateral lateral ventricles. No dilation of the fourth ventricle was observed. On contrast-enhanced CT scan, the lesion showed minimal peripheral enhancement without any demonstrable solid enhancing component. The maximum size of the lesion measured 73 mm × 65 mm × 64 mm in size (Figure [4](#F4){ref-type="fig"}).

![Magnetic resonance imaging. Magnetic resonance imaging revealed a large, lobulated and septated lesion arising from the third ventricle that was: A: Hypointense on T1 weighted imaging; B: Hyperintense on T2 weighted imaging; C: Heterogeneously hyperintense on T2 axial FLAIR imaging; D: Appeared diffusely restricted on diffusion weighted imaging.](WJR-11-74-g003){#F3}

![Minimal peripheral enhancement without any demonstrable solid enhancing component. The maximum size of the lesion measures 73 mm × 65 mm × 64 mm in size.](WJR-11-74-g004){#F4}

On MR spectroscopy, there was high lipid/lactate peak with comparatively lower N-acetylaspartate (NAA) and choline levels. The maximum choline (Cho)/creatine ratio was 2.85 within the lesion and CHO/NAA ratio was 0.766 (Figure [5](#F5){ref-type="fig"}). MR perfusion derived relative cerebral blood volume (rCBV) maps demonstrating heterogeneous perfusion abnormalities. Mild higher normalized rCBV ratios in comparison with white matter were noted in the peripheral region of the cyst, which corresponded to malignant transformation (Figure [6](#F6){ref-type="fig"}).

![MR spectroscopy. High lipid/lactate peak with comparatively lower N-acetylaspartate and choline levels. Maximum choline/creatine ratio was 2.85 within the lesion and choline/N-acetylaspartate ratio being 0.766.](WJR-11-74-g005){#F5}

![MR perfusion derived relative cerebral blood volume maps demonstrate heterogeneous perfusion abnormalities. Mild higher normalized relative cerebral blood volume ratios in comparison with white matter are noted in the peripheral region of the cyst, which corresponds to malignant transformation.](WJR-11-74-g006){#F6}

FINAL DIAGNOSIS
===============

Considering the imaging findings, we suspected the lesion to be an epidermoid, dermoid, or an arachnoid cyst. However, we ruled out the diagnosis of a dermoid or arachnoid cyst considering the presence of a restricted diffusion on diffusion-weighted imaging (DWI). A combination of T1WI, T2WI, T2 axial FLAIR, and DW imaging techniques helped us diagnose an epidermoid cyst. However, the use of MR spectroscopy helped in making the probable diagnosis of a malignant epidermoid cyst arising from the third ventricle.

TREATMENT
=========

The patient underwent craniotomy coupled with intra-hemisphere excision of the tumor. The patient was given levetiracetam 500 mg twice a day.

OUTCOME AND FOLLOW-UP
=====================

The patient is stable and currently doing well.

DISCUSSION
==========

Epidermoid cysts are slow-growing and often benign congenital tumors that comprise 0.2%-1.8% of primary intracranial neoplasms\[[@B4]\]. The first epidermoid cysts were described by an artist in 1807 in a French medical school\[[@B5]\]. The French pathologist Cruveilhier gave the first full description of epidermoid cysts\[[@B6]\]. From a histological point of view, epidermoid cysts often resemble the linear growth rate of the skin\[[@B5]\]. They are made up of a thin epithelium lining that appears pearly white and smooth macroscopically. Epidermoid tumors often have a high content of cholesterol and an internal core composed of desquamated epithelial keratin that is distinctive on MR imaging and allied radiological modalities\[[@B5]\].

To the best of our knowledge, intracranial epidermoid cysts are located off the midline. The most common location of epidermoids includes the region within the cerebellopontine angle (CPA)\[[@B7]\]. Intracranial epidermoids account for the third most common tumor in the CPA region followed by vestibular schwannoma and meningioma\[[@B7]\].

There have been more than 100 cases of epidermoids reported in the fourth ventricle, followed by the parasellar and sellar regions\[[@B8]\]. However, epidermoids may also be found in the lobes of the cerebral hemisphere, spine, and brainstem\[[@B8]\].

To the best of our knowledge, third ventricular epidermoid tumors are extremely rare. Patients with epidermoid tumors often present with signs and symptoms such as headache, seizures, cranial nerve defects, raised intracranial pressure, and cerebral signs\[[@B8]\]. Our patient presented with headache and vomiting.

Epidermoids appear as well-defined lobulated, round hypoattenuated masses on CT imaging. However, there have been reports where uniformly hyperdense epidermoids have been reported on CT imaging, which are associated with a calcium constitution or high protein content\[[@B9],[@B10]\]. Epidermoids appear hyperintense on T2 weighted and hypointense on T1 weighted MRI imaging\[[@B7]\]. In our case, we observed a hyperintense T2 weighted mass on MRI imaging. Lastly, MR spectroscopy showed an increase in the lactate peak, which was indicative of anaerobic metabolism. There was an increase in the Cho/NAA ratio, which is generally observed in neoplasms. The Cho/Cr ratio increased to 2.85.

As per current evidence, the major differential diagnosis for a third ventricle includes arachnoid cyst, cystic neoplasm, and dermoid cyst. The differential diagnosis of different third ventricle masses based on different sequences has been mentioned in Table [1](#T1){ref-type="table"}. Arachnoid cysts often appear less lobulated and follow a signal intensity patterns similar to those of cerebrospinal fluid with all MR pulse sequences including DWI and FLAIR\[[@B11]\]. Cystic neoplasms, such as cystic ependymoma and cystic medulloblastoma, have a varied appearance on imaging due to the varying degrees of necrosis, calcification, and hemorrhage. The solid component of these lesions often shows heterogeneous contrast enhancement and restriction on DWI\[[@B11]\]. Dermoid cysts are similar to epidermoid cysts, as both are lined by stratified squamous epithelium. In the context of imaging, dermoid cysts show a hyperintense signal on T1-weighted images while they appear as well-defined low attenuating (fat density) lobulated masses on CT scan\[[@B11]\].

###### 

Differential imaging considerations

  **Sequences**     **Epidermoid**                                              **Dermoid**                    **Arachnoid cyst**             **Cystic lesions medulloblastoma**                                **Cystic lesions ependymoma**
  ----------------- ----------------------------------------------------------- ------------------------------ ------------------------------ ----------------------------------------------------------------- ---------------------------------------------------
  T1WI              Hypointense                                                 Hyperintense                   Hypointense                    Hypointense                                                       Hypointense (Solid part)
  T2WI              Iso-hyperintense                                            Hypo-hyperintense              Hyperintense                   Heterogenous due to calcification, necrosis, and cyst formation   Foci of blooming (hemorrhage/calcification)
  FLAIR             Heterogenous signal higher than CSF                         Hyperintense                   Hypointense                    Heterogeneous signal higher than CSF                              Heterogeneous signal higher than CSF
  DWI               Restricted diffusion                                        No restriction                 No restriction                 Restricted diffusion                                              Restricted diffusion (Solid part)
  Contrast          Non enhancement (in malignant transformation it enhances)   Non-enhancement                Non-enhancement                Heterogeneous enhancement                                         Heterogeneous enhancement
  MR spectroscopy   Choline: + NAA: - Cho/Crt: +                                Choline: + NAA: - Cho/Crt: +   Choline: + NAA: - Cho/Crt: +   Choline: ++ NAA: - Cho/Crt: ++ Lipid: + Lactate: +                Choline: ++ NAA: - Cho/Crt ++ Lipid: + Lactate: +
  MR perfusion      \-                                                          \-                             \-                             +++ (solid part)                                                  +++

T1WI: T1 weighted image; T2WI: T2 weighted image; FLAIR: Fluid-attenuated inversion recovery; DWI: Diffusion weighted image; NAA: N-acetylaspartate.

The patient underwent craniotomy coupled with intra-hemisphere excision of the tumor. The procedure was uneventful. The patient was administered levetiracetam 500 mg twice a day. The patient is currently doing well. The diagnosis of malignant transformation of an epidermoid cyst arising from the third ventricle is challenging. Our key strengths involved our multidisciplinary approach in diagnosing, treating, and managing the patient. Non-invasive imaging modalities such as MR spectroscopy helped us confirm the diagnosis of a malignant epidermoid cyst from the third ventricle.

CONCLUSION
==========

We have presented a rare case of a third ventricular lesion presumed to be an epidermoid tumor as seen on MRI. The use of multimodality imaging can help radiologists diagnose uncommon tumors in unusual sites. The combination of CT, MRI, and MR spectroscopy was useful in confirming the diagnosis of a malignant epidermoid cyst arising from the third ventricle, an unusual site in routine practice.
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